BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37043130)

  • 1. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma.
    Gao Y; Li M; Wang B; Ma Y
    Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis.
    Gao Y; Wan L; Li M; Wang B; Ma Y
    Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Jiang X; Zhou X; Yu X; Chen X; Hu X; Lu J; Zhao H; Cao Q; Gu Y; Yang Y; Jiang W; Jin M
    Mod Pathol; 2022 Jul; 35(7):929-937. PubMed ID: 35194221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
    Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
    Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
    Wang Z; Zhang J; Li M; Kong L; Yu J
    Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
    Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
    J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy.
    Akaishi R; Fujishima F; Ishida H; Tsunokake J; Yamauchi T; Gokon Y; Ueki S; Fukutomi T; Okamoto H; Takaya K; Sato C; Taniyama Y; Nakamura T; Nakaya N; Kamei T; Sasano H
    Cancer Rep (Hoboken); 2022 Mar; 5(3):e1477. PubMed ID: 34264023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
    Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
    Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
    Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
    J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
    Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
    J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Expression of NRF2 Target Genes after Alcohol Exposure in the Background Esophageal Mucosa of Patients with Esophageal Squamous Cell Carcinoma.
    Toda S; Hatta W; Asanuma K; Asano N; Ono Y; Abe H; Ogata Y; Saito M; Kanno T; Jin X; Uno K; Koike T; Imatani A; Hamada S; Nakamura T; Nakaya N; Masamune A
    Tohoku J Exp Med; 2022 Oct; 258(3):195-206. PubMed ID: 36070895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Peng J; Hu Q; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Wei W; Liu S; Wang H
    Diagn Pathol; 2013 Oct; 8():177. PubMed ID: 24152793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma.
    Akaishi R; Fujishima F; Ishida H; Tsunokake J; Yamauchi T; Gokon Y; Ueki S; Fukutomi T; Okamoto H; Takaya K; Sato C; Taniyama Y; Nakamura T; Nakaya N; Kamei T; Sasano H
    Esophagus; 2022 Jul; 19(3):436-443. PubMed ID: 34999996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
    Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
    Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
    Wang JD; Ma J; Wang FY; Peng LB; Wang X; Shi SS; Ma HH; Lu ZF; Lu GM; Zhou XJ
    Dis Esophagus; 2013; 26(7):737-45. PubMed ID: 23317107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
    Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective expression of C20orf54 in esophageal dysplasia: a possible biomarker of esophageal carcinoma for early detection.
    Li M; Kong J; Wang L; Yan H; Liang W; Wang N; Zhao J
    World J Surg Oncol; 2022 May; 20(1):155. PubMed ID: 35549728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
    Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
    Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.
    Zhang Z; Xiong R; Li C; Xu M; Guo M
    Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.